Biliary Tract Neoplasms Clinical Trials in Beijing
2 recruitingBeijing, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Phase II Study of Adjuvant Durvalumab Combined With GEMOX/GC Chemotherapy Followed by Lenvatinib Versus Capecitabine in Biliary Tract Cancer.
Biliary Tract Neoplasms Immunotherapy
Peking Union Medical College Hospital222 enrolled1 locationNCT07679399
Recruiting
Phase 2
Phase II Study of Trastuzumab Rezetecan Combined With Adebrelimab and Lenvatinib as First-Line Therapy for Advanced HER2-Positive/HER2-Low Biliary Tract Cancer
Biliary Tract Neoplasms Immunotherapy
Peking Union Medical College Hospital70 enrolled1 locationNCT07670273